Genetic mutations in BRAF V600E are linked to higher disease-specific mortality, lymph node metastasis, extrathyroidal extension, an elevated risk of recurrence, distant metastasis, advanced disease stages, and older patient age [18,23,24]. Here, BRAF is linked to metastatic malignant neoplasm in the lymph nodes.